Cited by 1,010Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 142 of the 146 references it cites were found in a registry or an index.

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Wild, Robert A., Carmina, Enrico, Diamanti-Kandarakis, Evanthia, Dokras, Anuja, Escobar-Morreale, Hector F., Futterweit, Walter, Lobo, Rogerio, Norman, Robert J., Talbott, Evelyn, Dumesic, Daniel A.·2010·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2009-2724

Open this paper in CoChat — free account

Abstract

OBJECTIVE: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. PARTICIPANTS: An expert panel in PCOS and CVD reviewed literature and presented recommendations. EVIDENCE: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. CONSENSUS PROCESS: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. CONCLUSIONS: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist.

Integrity signals

Registry

Crossref · 10.1210/jc.2009-2724

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
Retracted
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“In two large intervention studies, almost 60% relative risk reduction in conversion to diabetes mellitus occurred in obese individuals (BMI, 30 kg/ m(2)) with IGT randomized to intensive lifestyle modification to reduce body weight by 5–7% (101, 102); less dramatic improvement occurred in less obese individuals (BMI,…”
Background
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457

Show all 146 references

Research works printed but not linked: 1

Zawadki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377

Sorted by citations

Items 601–700 of 1,000

Proinsulina, adiponektyna i hsCRP u kobiet w wieku rozrodczym z zespołem policystycznych jajników (PCOS) — wpływ leczenia metforminą
Kruszyńska, A., Slowinska-Srzednicka, J., Jeske, W., & Zgliczyński, W. (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0001 · Cited by 9
Women’s Health
Ring, M. R. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.02.012 · Cited by 11
The relationship between carotid intima-media thickness and endogenous androgens in young women with polycystic ovary syndrome in Taiwan
Teng, H., Chien, Y., Hsu, M.-I., & Chen, C.-I. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.736553 · Cited by 9
The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome
BİÇER, N. Ç., Ermiş, A. A., & Baş, D. (2023) · Life · doi:10.3390/life13101959 · Cited by 10
Unmasking the morphological alteration of erythrocytes among women suffering from PCOS
Dey, S., Chakraborty, I., Biswas, P., Paul, A., Chakraborty, P., & Haldar, R. (2024) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2023.102821 · Cited by 8
Transgenerational Effects and Mechanisms of Tributyltin Exposure on Neurodevelopment in the Male Offspring of Rats
Cai, H., Chen, M., Gao, Y., Ruan, J., He, C., & Zuo, Z. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c01546 · Cited by 8
Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset
Espinós, J. J., Rodrı́guez-Espinosa, J., Ordóñez‐Llanos, J., & Calaf, J. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.613968 · Cited by 8
Actualización del manejo de síndrome de ovario poliquístico
Gaitán, E. S. (2019) · Revista Medica Sinergia · doi:10.31434/rms.v4i12.322 · Cited by 8
Cardiovascular health and menopause in aging women with polycystic ovary syndrome
Helvacı, N., & Yıldız, B. O. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1719067 · Cited by 8
Ultrasonographic and biochemical assessments as early prediction of polycystic ovarian syndrome in obese women
Ahmed, A., Moselhy, S. S., Kumosani, T., Huwait, E. A., Al-Ghamdi, M. A., AL-Madani, K. A., AlToukhi, M. H., & Kumosani, A. T. (2020) · African Health Sciences · doi:10.4314/ahs.v20i2.18 · Cited by 8
Does polycystic ovary syndrome with phenotype D affect the cardiovascular endurance, core endurance, body awareness, and the quality of life? A prospective, controlled study
Doğan, H., & Çaltekin, M. D. (2021) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2021.72547 · Cited by 8
Relationship between loci of control and health-promoting behaviors in Pakistani women with polycystic ovary syndrome: coping strategies as mediators
Fatima, I., Yaqoob, S., Jamil, F., & Butt, A. A. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01489-w · Cited by 8
Pathophysiology of Polycystic Ovarian Syndrome
Manu, Soni, T., Victoria, V., & Prabhakar, P. K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101921 · Cited by 10
Metoclopramide Test in Hyperprolactinemic Women With Polycystic Ovarian Syndrome: Old Wine Into New Bottles?
Rodier, C., Courbière, B., Fernandes, S., Vermalle, M., Bretelle, F., Resseguier, N., Brue, T. C., & Cuny, T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.832361 · Cited by 8
Parameter study on characteristic pulse diagram of polycystic ovary syndrome based on logistic regression analysis
Wang, W., Zeng, W., Chen, X., Tu, L., Xu, J., & Yin, X. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2158317 · Cited by 8
Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease
Lin, W.-R., Liu, K., Ling, T., Wang, M., & Lin, W. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i4.352 · Cited by 8
Impact of Adverse Gestational Milieu on Maternal Cardiovascular Health
Alkhatib, B., Salimi, S., Jabari, M., Padmanabhan, V., & Vyas, A. K. (2023) · Endocrinology · doi:10.1210/endocr/bqad060 · Cited by 8
Utility of Hemoglobin-A1C in Nondiabetic Women With Polycystic Ovary Syndrome
Mortada, R. A., Comerford, K. B., Kallail, K. J., & Karakas, S. E. (2013) · Endocrine Practice · doi:10.4158/ep12123.or · Cited by 8
Polycystic ovary syndrome and molecular approaches
Aydos, A., Islakoğlu, Y. Ö., & Dedeoğlu, B. G. (2016) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2016.09327 · Cited by 8
Assessment of insulin resistance and metabolic syndrome in young reproductive aged women with polycystic ovarian syndrome: analogy of surrogate indices
Rashid, N., Nigam, A., Kauser, S., Prakash, P., Jain, S. K., & Wajid, S. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1724157 · Cited by 8
Polycystic Ovary Syndrome
Connolly, A., & Beckett, V. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316537398.016 · Cited by 8
2D Diffusion‐Ordered 1H‐NMR Spectroscopy Lipidomic Profiling after Oral Single Macronutrient Loads: Influence of Obesity, Sex, and Female Androgen Excess
Insenser, M. R., Moncayo, S., Martínez-García, M. Á., Fernández‐Durán, E., Samino, S., Álvarez‐Blasco, F., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900928 · Cited by 8
Self-citation
Unraveling PCOS: Exploring its causes and diagnostic challenges
Dar, M. A., Maqbool, M., Qadrie, Z., Ara, I., & Qadir, A. (2024) · Open Health · doi:10.1515/ohe-2023-0026 · Cited by 7
A combination of gliclazide and metformin attenuates obesity-induced polycystic ovary syndrome in female Wistar rats
Moazzam, A., Saleem, A., Shah, S., Hussain, L., Baig, M. M. F. A., Alshammari, A., Albekairi, N. A., & Akhtar, M. F. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29015 · Cited by 7
Prevalence and correlates of diagnosed and probable polycystic ovary syndrome (PCOS) in a cohort of parous women
Perng, W., Fitz, V. W., Salmon, K., Hivert, M., Kazemi, M., Rifas‐Shiman, S. L., Shifren, J. L., Oken, E., & Chavarro, J. E. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae179 · Cited by 7
Metabolic dysregulation and gut dysbiosis linked to hyperandrogenism in female mice
Chen, A., Handzel, A. A., Sau, L., Cui, L. J., Kelley, S. T., & Thackray, V. G. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.443 · Cited by 8
Genetic variants in central metabolic genes influence some but not all relations of inflammatory markers in a collective with polycystic ovary syndrome
Knebel, B., Lehr, S., Janssen, O. E., Hahn, S., Nitzgen, U., Jacob, S., Haas, J., Müller‐Wieland, D., & Kotzka, J. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.697903 · Cited by 7
Polycystic Ovary Syndrome Endocrine and Cardio-Metabolic Abnormalities: how to Manage?
Georgescu, C. E. (2015) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2015.77 · Cited by 7
Challenges in Cardiovascular Risk Prediction and Stratification in Women
Henry, S. A., Bond, R. M., Rosen, S. E., Grines, C. L., & Mieres, J. H. (2019) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2017.0068 · Cited by 7
Smoking reduces ovarian stromal blood flow in polycystic ovary syndrome patients
Özay, Ö. E., & Özay, A. C. (2020) · Ginekologia Polska · doi:10.5603/gp.2020.0041 · Cited by 8
Polycystic Ovarian Syndrome: Impact on Adult and Fetal Health
Martini, A. E., & Healy, M. W. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000593 · Cited by 8
Developmental origins of polycystic ovary syndrome: Everything starts in utero
Abbott, D. H., Greinwald, E. P., & Levine, J. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00009-2 · Cited by 9
Effects of Vitamin D Deficiency in Polycystic Ovarian Syndrome
Al-Ghanny, R. J. A., Al‐Mosawi, M., & Abd, B. A. (2022) · Iraqi Journal of Science · doi:10.24996/ijs.2022.63.1.4 · Cited by 7
A Systematic Review: Ayurvedic Herbal Medicine for Women with Polycystic Ovary Syndrome
Dhankani, M. A., Patil, H. J., & Dhankani, A. R. (2023) · International Electronic Conference on Biomedicines (IECBM) · doi:10.3390/ecb2023-14362 · Cited by 7
PCOS: Perspectives from a Pediatric Endocrinologist and a Pediatric Gynecologist
Kansra, A. R., & Menon, S. (2013) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2013.01.002 · Cited by 7
Ethinylestradio-Chlormadinone Acetate Combination for the Treatment of Hirsutism and Hormonal Alterations of Normal-Weight Women With Polycystic Ovary Syndrome: Evaluation of the Metabolic Impact
Guido, M., Romualdi, D., Campagna, G., Ricciardi, L., Bompiani, A., & Lanzone, A. (2010) · Reproductive Sciences · doi:10.1177/1933719110371515 · Cited by 7
Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome
Enkhmaa, B., Anuurad, E., Zhang, W., Abbuthalha, A., Kaur, P., Visla, J., Karakas, S. E., & Berglund, L. (2015) · Clinical Endocrinology · doi:10.1111/cen.12937 · Cited by 7
Suitability of the National Health Care Surveys to Examine Behavioral Health Services Associated with Polycystic Ovary Syndrome
Sanchez, N. (2016) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-016-9543-6 · Cited by 7
Application of a Standard Cross-Specialty Workup for Diagnosis and Metabolic Screening of Obese Adolescents With Polycystic Ovary Syndrome
Huguelet, P. S., Olson, E., Sass, A. E., Bartz, S., Hsu, S. C., & Cree‐Green, M. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.07.008 · Cited by 7
The effect of lifestyle physical activity in reducing cardiovascular disease risk factors (blood pressure and cholesterol) in women: A systematic review
Akgöz, A. D., Özer, Z., & Gözüm, S. (2020) · Health Care For Women International · doi:10.1080/07399332.2020.1828422 · Cited by 7
Meta‐analysis of the correlation between IL ‐6 –174 G/C polymorphism and polycystic ovarian syndrome
Wang, Q., Tong, X., Ji, Y., Li, H., Lu, W., & Song, Z. (2015) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12682 · Cited by 7
Thyroid autoimmunity in different phenotypes of polycystic ovary syndrome: a single-center experience
Benelli, E., Marradi, M., Sciarroni, E., Cosmo, C. D., Bagattini, B., Ghianda, S. D., Simoncini, T., Fruzzetti, F., Tonacchera, M., & Fiore, E. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02404-4 · Cited by 6
Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Polycystic Ovary Syndrome in East Asia: A Review and Meta-Analysis
Wu, Z., Liang, G., Zhang, Y., & Li, R. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.01.011 · Cited by 6
Alterations of insulin sensitivity, clearance, and secretion, either alone or in combination, in women with PCOS: impact on metabolic profile and androgenemia
Tosi, F., Lando, M. G., Rosmini, F., Lucarini, F., Fiorio, V., Zanolin, M. E., Fiers, T., Kaufman, J., & Moghetti, P. (2025) · Human Reproduction · doi:10.1093/humrep/deaf114 · Cited by 7
The role of miRNA-339-5p in the function of vascular endothelial progenitor cells in patients with PCOS
Zhang, J., Xu, W., Li, S., Zhang, J., Shang, Y., & Gui, J. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.09.017 · Cited by 7
Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women
Zhang, J., Tang, L., Kong, L., Wu, T., Xu, L., Pan, X., & Liu, G. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008583.pub3 · Cited by 7
Low-dose spironolactone abates cardio-renal disorder by reduction of BAX/inflammasome expression in experimentally induced polycystic ovarian syndrome rat model
Peter, M. U., Areloegbe, S. E. J., Akintayo, C. O., Oniyide, A. A., Aturamu, A., & Olaniyi, K. S. (2022) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2022-0176 · Cited by 6
Assessment of Health-Related Quality of Life Using PCOSQ Tool, Its Determinants and Coping Mechanisms Used by Women with Polycystic Ovarian Syndrome Attending Multidisciplinary Clinic in Mumbai, India
Joshi, B. N., Patil, A. D., Kokate, P., Akula, A., Shaikh, S. A., Tandon, D., & Nayak, A. (2022) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-022-01723-x · Cited by 8
A systematic review and meta-analysis of the correlation between polycystic ovary syndrome and irritable bowel syndrome
Wei, Z., Chen, Z., Xiao, W., & Wu, G. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2239933 · Cited by 6
Understanding the Relationship between Polycystic Ovarian Syndrome (PCOS) and Dyslipidemia
Amadi, C. F., Okolonkwo, B. N., George-Oparati, M. I., & Odiabara, K. K. (2023) · Asian Journal of Biochemistry Genetics and Molecular Biology · doi:10.9734/ajbgmb/2023/v15i3333 · Cited by 8
Obesity in Polycystic Ovary Syndrome: Insulin Sensitizing Therapy
Hoeger, K. M. (2012) · Current Obesity Reports · doi:10.1007/s13679-012-0030-y · Cited by 6
Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review
Palomba, S., Materazzo, C., Falbo, A. I., Orio, F., Sala, G. B. L., & Sultan, C. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.876001 · Cited by 6
Vascular compliance in women with polycystic ovary syndrome treated with spironolactone
Muneyyirci‐Delale, O., Co, S., & Winer, N. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13385 · Cited by 6
Role ofpreconception endothelial dysfunction in development of obstetric complications
Kuznetsova, I. V. (2019) · Medical alphabet · doi:10.33667/2078-5631-2019-1-1(376)-53-58 · Cited by 7
Postpartum weight retention in women with polycystic ovary syndrome
Lee, I. T., Alur-Gupta, S., Gallop, R., & Dokras, A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.07.033 · Cited by 6
Self-citation
Anandamide is associated with waist-to-hip ratio but not with Body Mass Index in women with polycystic ovary syndrome
Kabakchieva, P., GATEVA, A., Velikova, T. V., Georgiev, T., & KAMENOV, Z. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03336-4 · Cited by 6
Polycystic Ovary Syndrome
Waldman, I. N., & Legro, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813209-8.00026-1 · Cited by 6
Unraveling the Connection between PCOS and renal Complications: Current insights and Future Directions
Peng, H., Ren, J., Zhao, Y., Fang, X., Wang, X., Liu, C., & Wan, Z. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112235 · Cited by 7
Contraception today and family planning: a comprehensive review and position statement on the ethical, medical, and social dimensions of modern contraception
Genazzani, A. R., Fidecicchi, T., Arduini, D., Benagiano, G., Birkhaeuser, M. H., Schenker, J. G., Strauss, J. F., Awad, D. V., Arnal, J., Bahamondes, L. G., et al. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2543423 · Cited by 5
Body composition analysis in women with polycystic ovary syndrome: a cross-sectional study from the Tehran Lipid and Glucose Study (TLGS)
Zakeri, A., Ebadinejad, A., Rahmati, M., Momenan, A. A., Niroomand, M., Valizadeh, M., Azizi, F., Tehrani, F. R., & Hosseinpanah, F. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01783-2 · Cited by 5
Determination of Neurodegeneration in Polycystic Ovary Syndrome with Retinal Segmentation Analysis
Sırakaya, E., Sırakaya, H. A., Vural, E., Duru, Z., & Aksoy, H. (2020) · Current Eye Research · doi:10.1080/02713683.2020.1842460 · Cited by 5
Etanercept Ameliorates Vascular, Endocrine, and Ovarian Changes in a Rat Model of DHEA-Induced Polycystic Ovary Syndrome
Korun, Z. E. U., Göçmez, S. S., Rençber, S. F., Sarıhan, K. K., ERALDEMİR, F. C., & Şahin, D. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01392-9 · Cited by 5
Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome
Chen, S., Guo, Z., & Yu, Q. (2023) · Human Genomics · doi:10.1186/s40246-023-00550-z · Cited by 5
Protocol for a randomized comparative effectiveness trial comparing a very low-carbohydrate diet to DASH diet for polycystic ovary syndrome: the SUPER (Supporting Understanding of PCOS Education and Research) trial
Greenwell, S., Jones, A., Smith, Y. R., Marriott, D. J., Aikens, J. E., Padmanabhan, V., & Saslow, L. R. (2024) · Trials · doi:10.1186/s13063-024-08583-y · Cited by 6
Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention
Mani, H., Khunti, K., Levy, M. J., & Davies, M. J. (2013) · Diabetes Management · doi:10.2217/dmt.13.54 · Cited by 5
Education and self-management for women with polycystic ovary syndrome; a narrative review of literature
Mani, H., Khunti, K. K., Daly, H., Barnett, J., & Davies, M. J. (2015) · Ibnosina Journal of Medicine and Biomedical Sciences · doi:10.4103/1947-489x.210263 · Cited by 5
Abdominal Obesity is Associated With a Lower Ankle–Brachial Index in Women With Polycystic Ovary Syndrome
Dogan, M. I., Taşçı, İ., Bulucu, F., Aydoğdu, A., Acar, R., Ceyhan, T., Koç, B., Demir, O., Gezer, M., & Sağlam, K. (2012) · Angiology · doi:10.1177/0003319711436248 · Cited by 5
Renal resistive index in patients with polycystic ovary syndrome
Tüfekçioğlu, G., Keşkek, Ş. Ö., Dılek, O., & Yılmaz, C. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000141 · Cited by 5
Clinical profile of 500 cases of Polycystic Ovary Syndrome in a Tertiary Hospital
Mahjabeen, N., Nasreen, S. Z. A., & Mustary, F. (2020) · Bangladesh Journal of Obstetrics & Gynaecology · doi:10.3329/bjog.v33i1.43542 · Cited by 5
Bioinformatics Analysis of ceRNA Network Related to Polycystic Ovarian Syndrome
Li, Y., & Tan, Y. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/9988347 · Cited by 5
Circulating microparticles as indicators of cardiometabolic risk in PCOS
Yalameha, B., Nejabati, H. R., & Nouri, M. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.06.019 · Cited by 5
Assessment of early vascular changes in adult females with polycystic ovary syndrome: correlation with insulin resistance
Mousa, S., Saif, A., Fathy, M., Mansour, M., Elhamid, A. M. A., Atef, A., Galal, M. A., Saad, S., & Aboulsoud, S. H. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2210226 · Cited by 6
Risk of Periodontal Diseases in Women With Polycystic Ovary Syndrome: An Overview
Rathi, N., & Reche, A. R. (2023) · Cureus · doi:10.7759/cureus.47169 · Cited by 24
Polycystic Ovarian Syndrome Trend in a Nutshell
Mohammed, S., & Nayak, B. S. (2017) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2017.28 · Cited by 6
Polycystic ovarian syndrome: Assessment of approaches to diagnosis and cardiometabolic monitoring in UK primary care
Heald, A. H., Livingston, M. A., Holland, D., Robinson, J. C., Moreno, G. Y., Donnahey, G., Duff, C. J., Wu, P., & Fryer, A. A. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.13046 · Cited by 5
Pancreatic autoimmunity: An unknown etiology on patients with assisted reproductive techniques (ART)-recurrent reproductive failure
Alecsandru, D., Barrio, A., Andía, V., Cruz, E., Aparicio, P., Serna, J., Cruz, M., Pellicer, A., & García-Velasco, J. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203446 · Cited by 5
Distribution of anthropometric, clinical, and metabolic profiles of women with polycystic ovary syndrome across the four regions of India
Kaur, J., Patil, M., Kar, S., Jirge, P. R., & Mahajan, N. (2019) · The Onco Fertility Journal · doi:10.4103/tofj.tofj_7_19 · Cited by 5
Comparative evaluation of sonographic ovarian morphology of Indian women with polycystic ovary syndrome versus those of normal women
Ganie, M., Ahmed, S., Pahwa, S. S., Das, C., Mir, F., Nisar, S., Jehangir, M., Parveen, S., & Rashid, A. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.129108 · Cited by 5
Polycystic Ovarian Syndrome: Metformin or Thiazolidinediones for Cardiovascular Risk Reduction?
Janci, M. M., Smith, R. C., & Odegard, P. S. (2012) · Diabetes Spectrum · doi:10.2337/diaspect.25.4.229 · Cited by 5
Association between copy-number variation on metabolic phenotypes and HDL-C levels in patients with polycystic ovary syndrome
Knebel, B., Lehr, S., Janssen, O. E., Hahn, S., Jacob, S., Nitzgen, U., Müller‐Wieland, D., & Kotzka, J. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-4080-1 · Cited by 5
Machine Learning Prediction Models for Diagnosing Polycystic Ovary Syndrome Based on Data of Tongue and PulsePreprint
Wang, W., Zeng, W., He, S., Shi, Y., Tu, L., Chen, X., Yang, B., Xu, J., & Yin, X. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4095191 · Cited by 5
Vascular Markers among Young Women with CVD Risk Factors
Aminuddin, A., Ugusman, A., Salamt, N., & Muhajir, M. (2019) · Sains Malaysiana · doi:10.17576/jsm-2019-4810-17 · Cited by 4
Cardiovascular Health Does Not Change Following High-Intensity Interval Training in Women with Polycystic Ovary Syndrome
Kiel, I. A., Jones, H., Lionett, S., Røsbjørgen, R. E. N., Lydersen, S., Vanky, E., & Moholdt, T. T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061626 · Cited by 4
Visceral Adiposity Index as an Indicator for Menstrual Disturbance, Hormonal and Metabolic Dysfunction in Polycystic Ovarian Syndrome
Sharma, P., Sarkar, A., Kaur, H., Gupta, U., & Kumar, B. (2022) · Cureus · doi:10.7759/cureus.29796 · Cited by 4
A study of retinal changes in women with polycystic ovarian syndrome
Shiromani, S., Bhatnagar, K., Singh, P., Suman, S., Meena, S., & Parveen, S. (2022) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_36_22 · Cited by 4
Do Androgens Predict Cardiovascular Risk Including Cardiotrophin-1 Levels in Patients with Obese and Lean Polycystic Ovary Syndrome
Yasar, H. (2022) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2022.466 · Cited by 4
Assessment of Cardiac Autonomic Function in Women With Polycystic Ovary Syndrome Through Ewing's Battery, Heart Rate Variability Analysis, and Composite Autonomic Symptom Score-31 Scale
Shrivastava, R., Pathak, T., Shrivastava, P., Patel, S. N., Chouhan, S., Singh, R., Parashar, R., & Mishra, S. (2023) · Cureus · doi:10.7759/cureus.45580 · Cited by 4
Correlation of AMH with Cardiometabolic Markers in Polycystic Ovarian Syndrome: Systematic Review and Meta-Analysis
Kamboj, S., Banerjee, S., Das, G., Thakkar, S., Atluri, R., Shivakumar, S., & Tiwari, H. D. (2024) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_553_23 · Cited by 4
Evaluation of Some Hormones Total Antioxidant Capacity and Malondialdehyde Levels in Polycystic Ovarian Syndrome Women attending the gynecology Clinic at Nnewi
Ihim, A. C., Onyenekwe, C. C., Eze, N. N., Obi, P. C., Osakue, N. O., Awalu, J. C., & Ikwelle, T. A. (2024) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v14i5.6539 · Cited by 4
Association of Myo-Inositol and Microlipodispersed Magnesium in Androgen-Dependent Dermatological Diseases: A Retrospective Study
Pezza, M., Carlomagno, V., Sammarco, E., Trischitta, A., Ceddia, C., Vitiello, A., Baj, G., Citi, V., & Colletti, A. (2025) · Pharmaceuticals · doi:10.3390/ph18020251 · Cited by 5
Distribution of polycystic ovary syndrome (PCOS) phenotypes in Iranian women: a cross-sectional study
Kheirollahi, A., Hamidi, H., & Vatannejad, A. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07202-6 · Cited by 4
Serological Diagnosis of Helicobacter pylori Infection in Patients With a Polycystic Ovary Syndrome
Kiani, A. H., Asadbeik, E., Bibalan, M. H., Sedighi, M., Eshaghi, M., Gholami, M., & Pournajaf, A. (2015) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.10(2)2015.27432 · Cited by 4
Dangerous triplet: Polycystic ovary syndrome, oral contraceptives and Kounis syndrome
Erol, N. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i12.1285 · Cited by 4
Management of Acute Myocardial Infarction and its Effect on Women's Health (Female Versus Male)
Asghari, E., Sadeghi, M. R., Parizad, R., & jhale, N. M. (2014) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2014.29 · Cited by 4
Relationship between Polycystic Ovary Syndrome and Hyperuricemia
孙, 茹. (2017) · Open Journal of Natural Science · doi:10.12677/ojns.2017.52016 · Cited by 4
The relation of visceral adiposity index and lipid accumulation product with metabolic, anthropometric, and hormonal parameters in patients with polycystic ovary syndrome
Aydın, G. A., & Özgen, G. (2020) · Journal of Surgery and Medicine · doi:10.28982/josam.755729 · Cited by 4
Role of shear wave elastography in predicting the metabolic and androgenic alterations in patients with polycystic ovary syndrome
Turan, Ö. D., Tunçyürek, Ö., & Ertekin, E. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14835 · Cited by 4
Pregnancy outcome in PCOS patients: The effects of letrozol combined with exercise
Manteghi, G., Shahraki, Z., Moghadam, M. N., & Ghanbarpour, M. H. (2021) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-021-00142-z · Cited by 4
ESTILO DE VIDA E PADRÃO ALIMENTAR DE PACIENTES COM SÍNDROME DO OVÁRIO POLICÍSTICO: REVISÃO DE LITERATURA
Kolitski, M. F., Mazur, C. E., & Schmitt, V. (2022) · Visão Acadêmica · doi:10.5380/acd.v23i2.80891 · Cited by 4
Aerobic physical training impact on adipokines in women with polycystic ovary syndrome – Effects of body fat percentage
de Souza, H. C. D., Philbois, S. V., Facioli, T. D. P., Ferriani, R. A., & Gastaldi, A. C. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000503 · Cited by 5

Authors: Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A.
Affiliations: OU Health (US)
University of Palermo (IT)
University of Athens Medical School (E.D.-K.), 11527 Athens, Greece
University of Pennsylvania (US)
Hospital Ramon y Cajal (H.F.E.-M.), 28034 Madrid, Spain
Icahn School of Medicine at Mount Sinai (US)
Columbia University (R.L.), New York, New York 10027
The University of Adelaide (AU)
University of Pittsburgh (US)
University of Wisconsin–Madison (US)
Corresponding author: Carmina, Enrico
ORCID: Wild, Robert A.
Carmina, Enrico
Dokras, Anuja
Norman, Robert J.
Talbott, Evelyn
Dumesic, Daniel A.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2010-05-01
Volume: 95
Issue: 5
Pages: 2038-2049
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2009-2724
OpenAlex: W2105749473
Semantic Scholar: 5556ce96457d5a9ef1f00894a9f61047e5c6afb4
Cited by: 1,010
References: 146
Citations by year: 2026: 34 · 2025: 47 · 2024: 45 · 2023: 62 · 2022: 77 · 2021: 52 · 2020: 56 · 2019: 73 · 2018: 61 · 2017: 58 · 2016: 62 · 2015: 89 · 2014: 85 · 2013: 69 · 2012: 62
FWCI: 79.63
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: polycystic ovary syndrome, cardiovascular risk, cardiovascular disease prevention, hyperandrogenism, obesity, dyslipidemia, hypertension, impaired glucose tolerance, metabolic syndrome, type 2 diabetes, subclinical vascular disease, body mass index, waist circumference, oral glucose tolerance test, mood disorders, lifestyle management, insulin-sensitizing drugs, cardiovascular risk assessment
MeSH terms: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index, Glucose Intolerance, Risk Assessment, Waist-Hip Ratio, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks